Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
OtherMinireview

Phosphoproteomics-based characterization of Prostaglandin E2 signaling in T cells

Anna Mari Lone and Kjetil Taskén
Molecular Pharmacology March 4, 2021, MOLPHARM-MR-2020-000170; DOI: https://doi.org/10.1124/molpharm.120.000170
Anna Mari Lone
1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Mari Lone
Kjetil Taskén
2Dept of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kjetil Taskén
  • For correspondence: kjetil.tasken@medisin.uio.no
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

MOLPHARM-MR-2020-000170
DOI 
https://doi.org/10.1124/molpharm.120.000170
PubMed 
33674363

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online March 4, 2021.

Article Versions

  • You are currently viewing an Earlier version of this article (March 4, 2021 - 12:26).
  • earlier version (March 10, 2021 - 08:46).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Anna Mari Lone1 and
  2. Kjetil Taskén2,*
  1. 1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway
  2. 2Dept of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway
  1. ↵* Corresponding Author:
    Kjetil Taskén, Dept of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen 70, P.O.Box 4953 Nydalen, Oslo, N/A, N-0424, Norway. E-mail: kjetil.tasken{at}medisin.uio.no

Statistics from Altmetric.com

Article usage

Article usage: March 2021 to February 2023

AbstractFullPdf
Mar 20212960132
Apr 20217216957
May 20211814169
Jun 20212018051
Jul 20211610348
Aug 20211312450
Sep 20211815959
Oct 20211312095
Nov 20211710662
Dec 2021128340
Jan 20221914165
Feb 20221110736
Mar 202268158
Apr 2022128428
May 2022410353
Jun 202298438
Jul 2022811025
Aug 202287226
Sep 202284927
Oct 2022104327
Nov 202282724
Dec 202282614
Jan 2023112918
Feb 2023034

Next
Back to top

In this issue

Molecular Pharmacology: 103 (2)
Molecular Pharmacology
Vol. 103, Issue 2
1 Feb 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Phosphoproteomics-based characterization of Prostaglandin E2 signaling in T cells
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherMinireview

PGE2 signalling in T cells

Anna Mari Lone and Kjetil Taskén
Molecular Pharmacology March 4, 2021, MOLPHARM-MR-2020-000170; DOI: https://doi.org/10.1124/molpharm.120.000170

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherMinireview

PGE2 signalling in T cells

Anna Mari Lone and Kjetil Taskén
Molecular Pharmacology March 4, 2021, MOLPHARM-MR-2020-000170; DOI: https://doi.org/10.1124/molpharm.120.000170
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • AhR modulation in environmentally induced skin conditions
  • Wang and Hong
  • Ferroptosis and breast cancer
Show more Minireview

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics